GN Store Nord A/S

GN.CO

Medical - Devices · Healthcare

Exchange

NASDAQ Copenhagen

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Weak

Cash Flow

Mixed

Stability

Mixed

Valuation

Data not available

Track this stock — start free trial

Winston Score History

The full picture

GN Store Nord is a Danish company that makes two main types of products: hearing aids and audio headsets. Its hearing aid brand, ReSound, sells devices to people with hearing loss through audiologists and clinics. Its other division, Jabra, makes headsets and earbuds used by office workers, call centers, and everyday consumers.

The company earns money by selling hardware — both the hearing aids and the headsets are physical products, though some software and services are bundled in. GN operates globally, with strong presence in Europe and North America, and competes against larger rivals like Sonova and Demant in hearing care, and Poly and Plantronics in audio. The low ROIC of 3.4% reflects recent pressure on profitability, partly from heavy investment and a competitive headset market. The key growth driver is the hearing aid segment, where an aging global population is expanding demand, but the company faces ongoing pricing pressure and competition from tech giants like Apple entering the audio space.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-47.8% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-113.3% YoY

YoY Growth Rate

Earnings declining

Insider Activity

0.1%ownership

Relatively low insider ownership

Cash Runway

~8 months

kr 832M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

GN Store Nord A/S has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

49.5%

Healthy — 49.5% gross margin

Profit after running costs

Operating Margin

-0.7%

Losing money on operations — -0.7%

Return on the money invested

ROCE

3.1%

Weak — 3.1% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-25.0%

Shrinking sales (-25.0% YoY)

Profit growth

EPS YoY

-164.2%

Earnings shrinking (-164.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

14.8%

Converts sales into free cash efficiently (14.8%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

1.02

Elevated debt (1.02)

Covers its interest

Interest Cover

1.09x

Dangerous — barely covers interest (1.1x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial